In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice

被引:81
作者
Jacobs, P
Radzioch, D
Stevenson, MM
机构
[1] MCGILL UNIV,CTR STUDY HOST RESISTANCE,MONTREAL,PQ H3G 1A4,CANADA
[2] MCGILL UNIV,INST PARASITOL,ST ANNE BELLEVUE,PQ,CANADA
[3] MONTREAL GEN HOSP,RES INST,MONTREAL,PQ H3G 1A4,CANADA
关键词
D O I
10.1128/IAI.64.1.44-49.1996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated whether gamma interferon (IFN-gamma; a Th1 cytokine), tumor necrosis factor alpha (TNF-alpha), and interleukin-4 (IL-4; a Th2 cytokine) modulate nitric oxide (NO) production in vivo during blood stage infection with Plasmodium chabaudi AS. Treatment of resistant C57BL/6 mice, which resolve infection with P. chabaudi AS and produce increased levels of IFN-gamma, TNF-alpha, and NO early during infection, with anti-IFN-gamma plus anti-TNF-alpha monoclonal antibodies (MAbs) resulted in a reduction of both splenic inducible NO synthase mRNA and serum NO3- levels by 50 and 100%, respectively. Treatment with the anti-TNF-alpha MAb alone reduced only serum NO3- levels by 35%, and treatment with the anti-IFN-gamma MAb alone had no effect on NO production by these mice during infection, Susceptible A/J mice, which succumb to infection with P. chabaudi AS and produce increased levels of IL-4 but low levels of IFN-gamma, TNF-alpha, and NO early during infection, were treated with an anti-IL-4 MAb. The latter treatment had no effect on NO production by this mouse strain during infection, In addition, our results also demonstrate that treatment of resistant C57BL/6 mice with anti-IFN-gamma plus anti-TNF-alpha MAb affects, in addition to NO production, other traits of resistance to P. chabaudi AS malaria such as the peak level of parasitemia and the development of splenomegaly. Furthermore, the change in spleen weight was shown to be an IFN-gamma-independent effect of TNF-alpha. Treatment of susceptible A/J mice during infection with an anti-IL-4 MAb had no effect on these markers of resistance, Thus, these results demonstrate that TNF-alpha and IFN-gamma are critical in the regulation of NO production and other traits of resistance during P. chabaudi AS malaria in C57BL/6 mice. These data also indicate that treatment with an anti-IL-4 antibody alone is not able to induce NO production or confer resistance to A/J mice against P. chabaudi AS malaria.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 42 条
  • [1] ROLE OF MACROPHAGE-DERIVED NITRIC-OXIDE IN SUPPRESSION OF LYMPHOCYTE-PROLIFERATION DURING BLOOD-STAGE MALARIA
    AHVAZI, BC
    JACOBS, P
    STEVENSON, MM
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 58 (01) : 23 - 31
  • [2] ROLE OF GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR-ALPHA DURING T-CELL-INDEPENDENT AND T-CELL-DEPENDENT PHASES OF MYCOBACTERIUM-AVIUM INFECTION
    APPELBERG, R
    CASTRO, AG
    PEDROSA, J
    SILVA, RA
    ORME, IM
    MINOPRIO, P
    [J]. INFECTION AND IMMUNITY, 1994, 62 (09) : 3962 - 3971
  • [3] BARRERA LF, 1994, IMMUNOLOGY, V82, P457
  • [4] BELOSEVIC M, 1989, J IMMUNOL, V143, P266
  • [5] MECHANISM OF SUPPRESSION OF NITRIC-OXIDE SYNTHASE EXPRESSION BY INTERLEUKIN-4 IN PRIMARY MOUSE MACROPHAGES
    BOGDAN, C
    VODOVOTZ, Y
    PAIK, J
    XIE, QW
    NATHAN, C
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 55 (02) : 227 - 233
  • [6] NITRIC-OXIDE PRODUCED DURING MURINE LISTERIOSIS IS PROTECTIVE
    BOOCKVAR, KS
    GRANGER, DL
    POSTON, RM
    MAYBODI, M
    WASHINGTON, MK
    HIBBS, JB
    KURLANDER, RL
    [J]. INFECTION AND IMMUNITY, 1994, 62 (03) : 1089 - 1100
  • [7] REDUCTION IN INSULITIS FOLLOWING ADMINISTRATION OF IFN-GAMMA AND TNF-ALPHA IN THE NOD MOUSE
    CAMPBELL, IL
    OXBROW, L
    HARRISON, LC
    [J]. JOURNAL OF AUTOIMMUNITY, 1991, 4 (02) : 249 - 262
  • [8] NITRIC-OXIDE IN CEREBRAL MALARIA
    COT, S
    RINGWALD, P
    MULDER, B
    MIAILHES, P
    YAPYAP, J
    NUSSLER, AK
    ELING, WMC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06) : 1417 - 1418
  • [9] CUNHA FQ, 1994, IMMUNOLOGY, V81, P211
  • [10] DING AH, 1988, J IMMUNOL, V141, P2407